Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose

Radiology

Volumn 179, Issue 3, 1991, Pages 765-770

  Wahl, Richard L ^a   Cody, Robert L ^a   Hutchins, Gary D ^a   Mudgett, Elizabeth E ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Breast neoplasms, diagnosis, 00.32, 00.33; Breast neoplasms, metastases, 00.33; Breast neoplasms, radionuclide studies, 00.121, 00.12987; Emission CT, 00.1299; Glucose; Radionuclide imaging, in diagnosis of neoplasms

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; BONE METASTASIS; BREAST CANCER; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SOFT TISSUE;

ADULT; AGED; BREAST NEOPLASMS; DEOXYGLUCOSE; FEASIBILITY STUDIES; FEMALE; FLUDEOXYGLUCOSE F 18; HUMAN; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0025911120     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.179.3.2027989     Document Type: Review

References (30)

1. Harris JR, Hellman S, Canellos GP, Fisher B. Cancer of the breast. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 2nd ed. Philadelphia: Lippincott, 1985.
2. Mansour EG, Gray R, Shatila AH, et al. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer: an intergroup study. N Engl J Med 1989; 320:485-490.
3. Sickles EA, ed. Breast imaging. Radiol Clin North Am 1987; 25:897-1047.
4. Gisvold JJ. Imaging of the breast: techniques and results. Mayo Clin Proc 1990; 65:56-66.
5. Muroff LR. Optimizing the performance and interpretation of bone scans. Clin Nucl Med 1981; 6(suppl 10S):68-76.
6. Warburg O. The metabolism of tumors. New York: Smith, 1931; 129-169.
7. Weber G, Banerjee G, Morris HP. Comparative chemistry of hepatomas. I. Carbohydrate enzymes in Morris hepatomas 5123. Cancer Res 1961; 21:933-937.
8. Som P, Atkins HL, Bandoypadhyay D, et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 1980; 21:670-675.
9. Larson SM, Weiden PL, Grunbaum Z, et al. Positron imaging feasibility studies. II. Characteristic of deoxyglucose uptake in rodent and canine neoplasms: concise communication. J Nucl Med 1981; 22:875-879.
10. Di Chiro G, DeLaPaz RL, Brooks RRA, et al. Glucose utilization of cerebral gliomas measured by 18F fluorodeoxyglucose and positron emission tomography. Neurology 1982; 32:1323-1329.
11. Yonekura Y, Benua RS, Brill AB, et al. Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med 1982; 23:1133-1137.
12. Paul R, Ahonen A, Roeda D, Nordman E. Imaging of hepatoma with 18F-fluorodeoxyglucose (letter). Lancet 1985; 1:50-51.
13. Kern KA, Brunetti A, Norton JA, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 1988; 29:181-186.
14. Strauss LG, Clorius JH, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989; 170:329-332.
15. Schelbert HR, Henze E, Phelps ME, Kuhl DE. Assessment of regional myocardial ischemia by positron-emission computed tomography. Am Heart J 1982; 103:588-597.
16. Frey KA: Positron emission tomography. In: Siegel GJ, Agranoff B, Albers RW, Molinoff P, eds. Basic neurochemistry: molecular, cellular, and medical aspects. 4th ed. New York: Raven, 1989; 839-855.
17. Wahl RL, Hutchins G, Liebert M, Grossman HB, Buchsbaum D, Fisher S. 18 FDG uptake in human tumor xenografts: feasibility studies for cancer imaging (abstr). J Nucl Med 1989; 30:912.
18. Wahl RL, Henry C, Ethier S. Serum glucose effects on the tumor and normal tissue uptake of FDG in rodents with breast carcinoma. J Nucl Med 1990; 31:888.
19. Wahl RL, Hutchins GD, Buchsbaum DJ, Liebert M, Grossman HB, Fisher S. 18F-2-deoxy-2-fluoro-d-glucose (FDG) uptake into human tumor xenografts: feasibility studies for cancer imaging with PET. Cancer 1991; 67:1544-1550.
20. Toorongian SA, Mulholland GK, Jewett DM, Bachelor MA, Kilbourn MR. Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. Int J Rad Appl Instrum [B] 1990; 17:273-279.
21. Soule HD, Vasquez J, Long A, Albert S, Brennan MJ. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973; 51:1409-1416.
22. Minn H, Soini I. 18F fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer Eur J Nucl Med 1989; 15:61-66.
23. Mintun MA, Welch MJ, Siegel BA, Mathias CJ, et al. Breast cancer: PET imaging of estrogen receptors. Radiology 1988; 169:45-48.
24. Beaney RP, Lammertsma AA, Jones T, McKenzie CG, Hainan KE. Positron emission tomography for in vivo measurement of regional blood flow, oxygen utilization and blood volume in patients with breast carcinoma. Lancet 1984; 1:131-134.
25. Hiraki Y, Rosen OM, Birnbaum MJ. Growth factors rapidly induce expression of the glucose transporter gene. J Biol Chem 1988; 263:13,655-13,662.
26. Di Chiro G, Oldfield E, Wright DC, et al. Cerebral necrosis after radiotherapy and/ or intraarterial chemotherapy for brain rumors: PET and neuropathologic studies. AJR 1988; 150:189-197.
27. Tahara T, Ichiya Y, Kuwabara Y, et al. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 1989; 13:829-831.
28. Abe Y, Matsuzawa T, Fujiwara T, et al. Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med 1986; 12:329-332.
29. 3H-deoxyglucose in the tumor model, following chemotherapy and radiotherapy. J Nucl Med 1985; 26:278-282.
30. Minn H, Paul R, Ahonen A. Evacuation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 1988; 29:1521-1525.